CV Sciences (CVSI) Depreciation & Amortization (CF) (2013 - 2026)
CV Sciences (CVSI) posted Depreciation & Amortization (CF) of $23000.0 for Q1 2026, up 9.52% sequentially from $21000.0 in Q4 2025, and down 71.95% YoY from $82000.0 in Q1 2025.
CV Sciences (CVSI) Depreciation & Amortization (CF) (2013 - 2026) Analysis & Trends
CV Sciences has reported Depreciation & Amortization (CF) for 14 years, with the latest figure at $23000.0 in Q1 2026.
- Quarterly Depreciation & Amortization (CF) fell 71.95% year-over-year to $23000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $133000.0 (down 62.32% YoY) and the FY2025 annual result came in at $192000.0, down 42.51% from the prior year.
- Depreciation & Amortization (CF) grew to $23000.0 in Q1 2026 per CVSI's latest filing, from $21000.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $517000.0 in Q1 2022 and troughed at $21000.0 in Q4 2025.
- A 5-year average of $104470.6 and a median of $63000.0 in 2022 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) jumped 153.43% in 2022, then sank 88.59% in 2023.
- Over 5 years, Depreciation & Amortization (CF) stood at $69000.0 in 2022, then decreased by 14.49% to $59000.0 in 2023, then soared by 93.22% to $114000.0 in 2024, then tumbled by 81.58% to $21000.0 in 2025, then climbed by 9.52% to $23000.0 in 2026.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $23000.0, $21000.0, and $31000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 241.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 24.20 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 672.30 Mn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 171.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn | 22,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22,000.00 |
| Jun 30, 2026 | 22,000.00 |
| Mar 31, 2026 | 23,000.00 |
| Mar 31, 2026 | 23,000.00 |
| Dec 31, 2025 | 21,000.00 |
| Dec 31, 2025 | 21,000.00 |
| Sep 30, 2025 | 31,000.00 |
| Sep 30, 2025 | 31,000.00 |
| Jun 30, 2025 | 58,000.00 |
| Jun 30, 2025 | 58,000.00 |
| Mar 31, 2025 | 82,000.00 |
| Mar 31, 2025 | 82,000.00 |
| Dec 31, 2024 | 114,000.00 |
| Dec 31, 2024 | 114,000.00 |
| Sep 30, 2024 | 81,000.00 |
| Sep 30, 2024 | 81,000.00 |
| Jun 30, 2024 | 76,000.00 |
| Jun 30, 2024 | 76,000.00 |
| Mar 31, 2024 | 63,000.00 |
| Mar 31, 2024 | 63,000.00 |